← Back to directory

Úrsula da Silveira Matte

Researcher Next ID · RN-038025

Researcher · Health Professions

Universidade Federal do Rio Grande do Sul

Porto Alegre, Brazil

Accepting doctoral researchersFunding unknown
Works count
548
Citation count
4,076
H-index
34
i10-index
127

Research interests

Health Professions
Medicine
Lysosomal Storage Disorders Research
Trypanosoma species research and implications
Liver physiology and pathology
Glycogen Storage Diseases and Myoclonus
Health, Medicine and Society

Publications

  • Mucopolysaccharidosis Type I

    Diagnostics · 2020 · 10.3390/diagnostics10030161

  • In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system

    Journal of Controlled Release · 2018 · 10.1016/j.jconrel.2018.08.031

  • Cationic nanoemulsions as nucleic acids delivery systems

    International Journal of Pharmaceutics · 2017 · 10.1016/j.ijpharm.2017.10.030

  • Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function

    Genes · 2017 · 10.3390/genes8120364

  • Emerging drugs for the treatment of mucopolysaccharidoses

    Expert Opinion on Emerging Drugs · 2016 · 10.1517/14728214.2016.1123690

  • Photobiomodulation regulates cytokine release and new blood vessel formation during oral wound healing in rats

    Lasers in Medical Science · 2016 · 10.1007/s10103-016-1904-0

  • Birth mode-dependent association between pre-pregnancy maternal weight status and the neonatal intestinal microbiome

    Scientific Reports · 2016 · 10.1038/srep23133

  • miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma

    Pancreas · 2015 · 10.1097/mpa.0000000000000383

  • An Analysis of the Global Expression of MicroRNAs in an Experimental Model of Physiological Left Ventricular Hypertrophy

    PLoS ONE · 2014 · 10.1371/journal.pone.0093271

  • Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression

    Biomarkers · 2014 · 10.3109/1354750x.2013.870605

  • Effects of FTO RS9939906 and MC4R RS17782313 on obesity, type 2 diabetes mellitus and blood pressure in patients with hypertension

    Cardiovascular Diabetology · 2013 · 10.1186/1475-2840-12-103

  • Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice

    Molecular Genetics and Metabolism · 2013 · 10.1016/j.ymgme.2013.03.005

  • Guidelines for the Management of Mucopolysaccharidosis Type I

    The Journal of Pediatrics · 2009 · 10.1016/j.jpeds.2009.07.005

  • CNS involvement in Fabry disease: Clinical and imaging studies before and after 12 months of enzyme replacement therapy

    Journal of Inherited Metabolic Disease · 2004 · 10.1023/b:boli.0000028794.04349.91

  • Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients

    Molecular Genetics and Metabolism · 2003 · 10.1016/s1096-7192(02)00200-7

Current projects

    No projects listed.